RDX98940

N/A

Report date: 2024/08/13 14:58:30
NME

Base Information

Drug NameRDX98940
Drug Alias NameRDX98940RDX-98940
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsG-protein coupled bile acid receptor 1 agonistsGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 1 receptorG-protein coupled bile acid receptor 1Glucagon-like peptide 2 receptor
Therapy Area/IndicationsDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArdelyx Inc
China Registration ClassN/A

Develop Information

Active CompaniesArdelyx Inc
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A